InvestorsObserver
×
News Home

How Will the Market React to Vanda Pharmaceuticals Inc. (VNDA) Stock Getting a Bearish Rating

Tuesday, September 29, 2020 11:53 AM | InvestorsObserver Analysts

Mentioned in this article

How Will the Market React to Vanda Pharmaceuticals Inc. (VNDA) Stock Getting a Bearish Rating

Vanda Pharmaceuticals Inc. (VNDA) stock is up 0.11% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bearish
Vanda Pharmaceuticals Inc. has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on VNDA!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.

Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.

InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.

For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With VNDA Stock Today?

Vanda Pharmaceuticals Inc. (VNDA) stock is trading at $9.41 as of 11:50 AM on Tuesday, Sep 29, an increase of $0.08, or 0.86% from the previous closing price of $9.33. The stock has traded between $9.23 and $9.47 so far today. Volume today is low. So far 136,637 shares have traded compared to average volume of 686,200 shares.

To see InvestorsObserver's Sentiment Score for Vanda Pharmaceuticals Inc. click here.

More About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company which is engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant (VLY-686), VTR-297, and VQW-765.

Click Here to get the full Stock Score Report on Vanda Pharmaceuticals Inc. (VNDA) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App